Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.

Goldenberg, Ronald M; Aroda, Vanita R; Billings, Liana K; Christiansen, A Sia Louise; Meller Donatsky, Anders; Parvaresh Rizi, Ehsan; Podgorski, Gracjan; Raslova, Katarina; Klonoff, David C; Bergenstal, Richard M

Goldenberg, Ronald M; Aroda, Vanita R; Billings, Liana K; Christiansen, A Sia Louise; Meller Donatsky, Anders; Parvaresh Rizi, Ehsan; Podgorski, Gracjan; Raslova, Katarina; Klonoff, David C; Bergenstal, Richard M.

Afiliação

Goldenberg RM; LMC Diabetes and Endocrinology, Concord, Ontario, Canada.
Aroda VR; Diabetes Clinical Research, Division of Endocrinology, Diabetes & Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Billings LK; Department of Medicine, NorthShore University HealthSystem/University of Chicago Pritzker School of Medicine, Skokie, Illinois, USA.
Christiansen ASL; Biostatistics, Insulin & Devices, Novo Nordisk, Søborg, Denmark.
Meller Donatsky A; Medical & Science, New Generation Insulins, Novo Nordisk, Søborg, Denmark.
Parvaresh Rizi E; Global Medical Affairs, Novo Nordisk, Søborg, Denmark.
Podgorski G; Internal Medicine, Greenacres Hospital, Port Elizabeth, South Africa.
Raslova K; Metabolic Center Ltd, Bratislava, Slovakia.
Klonoff DC; Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.
Bergenstal RM; International Diabetes Center and HealthPartners Institute, Minneapolis, MN, USA.

Diabetes Obes Metab ; 23(11): 2572-2581, 2021 11.

Article em En | MEDLINE | ID: mdl-34322967

Assuntos

Diabetes Mellitus Tipo 2; Hipoglicemia; Adulto; Glicemia; Automonitorização da Glicemia; Estudos Cross-Over; Diabetes Mellitus Tipo 2/tratamento farmacológico; Diabetes Mellitus Tipo 2/epidemiologia; Hemoglobinas Glicadas/análise; Humanos; Hipoglicemia/induzido quimicamente; Hipoglicemia/epidemiologia; Hipoglicemiantes/efeitos adversos; Insulina Glargina/efeitos adversos; Insulina de Ação Prolongada; Pessoa de Meia-Idade; Fatores de Risco

Palavras-chave

basal insulins; insulin analogues; insulin treatment; long-acting basal insulin; professional CGM; type 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google